NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,125 filers reported holding NOVARTIS A G in Q2 2020. The put-call ratio across all filers is 0.55 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,481,044 | +0.3% | 14,540 | -0.7% | 1.12% | +4.5% |
Q2 2023 | $1,477,322 | +9.7% | 14,640 | 0.0% | 1.07% | +6.4% |
Q1 2023 | $1,346,880 | +1.4% | 14,640 | 0.0% | 1.00% | +0.2% |
Q4 2022 | $1,328,140 | +19.3% | 14,640 | 0.0% | 1.00% | +2.2% |
Q3 2022 | $1,113,000 | -10.1% | 14,640 | -0.0% | 0.98% | -0.4% |
Q2 2022 | $1,238,000 | -4.1% | 14,642 | -0.5% | 0.98% | +11.9% |
Q1 2022 | $1,291,000 | +0.3% | 14,713 | 0.0% | 0.88% | +4.8% |
Q4 2021 | $1,287,000 | +6.3% | 14,713 | -0.6% | 0.84% | -28.4% |
Q3 2021 | $1,211,000 | -13.1% | 14,807 | -3.1% | 1.17% | -8.8% |
Q2 2021 | $1,394,000 | +7.4% | 15,273 | +0.6% | 1.28% | +24.5% |
Q1 2021 | $1,298,000 | -9.9% | 15,188 | -0.5% | 1.03% | -5.1% |
Q4 2020 | $1,441,000 | +8.6% | 15,263 | 0.0% | 1.09% | -14.0% |
Q3 2020 | $1,327,000 | -3.1% | 15,263 | -2.6% | 1.26% | -13.8% |
Q2 2020 | $1,369,000 | +8.5% | 15,671 | +2.4% | 1.47% | -4.4% |
Q1 2020 | $1,262,000 | -13.9% | 15,306 | -1.1% | 1.54% | +40.6% |
Q4 2019 | $1,466,000 | – | 15,481 | – | 1.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
PRENTISS SMITH & CO INC | 127,510 | $11,721,000 | 6.50% |
MANAGED ASSET PORTFOLIOS, LLC | 127,716 | $11,740,000 | 6.04% |
EXENCIAL WEALTH ADVISORS, LLC | 116,917 | $10,747,000 | 5.25% |
MCDANIEL TERRY & CO | 181,095 | $16,646,000 | 4.64% |
Fayerweather Charles | 18,180 | $1,671,000 | 4.54% |
Osher Van de Voorde Investment Management | 78,138 | $7,182,000 | 4.38% |
BROWN BROTHERS HARRIMAN & CO | 9,291,495 | $854,074,000 | 4.35% |
Boulegeris Investments, Inc. | 61,322 | $5,637,000 | 4.31% |
DODGE & COX | 45,723,035 | $4,202,861,000 | 4.23% |
WHV Investments, Inc. | 1,603,476 | $152,945,000 | 4.23% |